20-1578429-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_StrongBP6BP7
The NM_006065.5(SIRPB1):c.342C>T(p.Asp114=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000164 in 145,938 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.00016 ( 1 hom., cov: 29)
Exomes 𝑓: 0.0023 ( 516 hom. )
Failed GnomAD Quality Control
Consequence
SIRPB1
NM_006065.5 synonymous
NM_006065.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.00600
Genes affected
SIRPB1 (HGNC:15928): (signal regulatory protein beta 1) The protein encoded by this gene is a member of the signal-regulatory-protein (SIRP) family, and also belongs to the immunoglobulin superfamily. SIRP family members are receptor-type transmembrane glycoproteins known to be involved in the negative regulation of receptor tyrosine kinase-coupled signaling processes. This protein was found to interact with TYROBP/DAP12, a protein bearing immunoreceptor tyrosine-based activation motifs. This protein was also reported to participate in the recruitment of tyrosine kinase SYK. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 20-1578429-G-A is Benign according to our data. Variant chr20-1578429-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 2681546.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=-0.006 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SIRPB1 | NM_006065.5 | c.342C>T | p.Asp114= | synonymous_variant | 2/6 | ENST00000381605.9 | |
SIRPB1 | NM_001083910.4 | c.342C>T | p.Asp114= | synonymous_variant | 2/4 | ||
SIRPB1 | NM_001330639.2 | c.339C>T | p.Asp113= | synonymous_variant | 2/4 | ||
SIRPB1 | XM_005260641.4 | c.339C>T | p.Asp113= | synonymous_variant | 2/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SIRPB1 | ENST00000381605.9 | c.342C>T | p.Asp114= | synonymous_variant | 2/6 | 1 | NM_006065.5 |
Frequencies
GnomAD3 genomes AF: 0.000165 AC: 24AN: 145824Hom.: 1 Cov.: 29
GnomAD3 genomes
AF:
AC:
24
AN:
145824
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000190 AC: 47AN: 247668Hom.: 3 AF XY: 0.000224 AC XY: 30AN XY: 133888
GnomAD3 exomes
AF:
AC:
47
AN:
247668
Hom.:
AF XY:
AC XY:
30
AN XY:
133888
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00227 AC: 3088AN: 1362180Hom.: 516 Cov.: 31 AF XY: 0.00221 AC XY: 1502AN XY: 680278
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
3088
AN:
1362180
Hom.:
Cov.:
31
AF XY:
AC XY:
1502
AN XY:
680278
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000164 AC: 24AN: 145938Hom.: 1 Cov.: 29 AF XY: 0.000198 AC XY: 14AN XY: 70820
GnomAD4 genome
AF:
AC:
24
AN:
145938
Hom.:
Cov.:
29
AF XY:
AC XY:
14
AN XY:
70820
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
EBV-positive nodal T- and NK-cell lymphoma Benign:1
Likely benign, no assertion criteria provided | research | Department of Clinical Pathology, School of Medicine, Fujita Health University | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at